{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:41:11Z","timestamp":1786653671070,"version":"build-2736575974"},"reference-count":75,"publisher":"Society of Nuclear Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2026,7,8]]},"DOI":"10.2967\/jnumed.126.272587","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:40:41Z","timestamp":1786650041000},"page":"jnumed.126.272587","source":"Crossref","is-referenced-by-count":0,"title":["CXCR4-Targeted Molecular Imaging in Hematology and Oncology"],"prefix":"10.2967","author":[{"given":"Rudolf A.","family":"Werner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas K.","family":"Buck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Haug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francoise","family":"Kraeber-Bod\u00e9r\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin","family":"Lapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margret","family":"Schottelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian E.","family":"Serfling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Bodet-Milin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Raderer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Wegen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin G.","family":"Pomper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe M.","family":"Deroose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Kobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Gotthardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"2026081312401031000_jnumed.126.272587v1.1","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1007\/s00259-022-05849-y","article-title":"CXCR4-targeted theranostics in oncology","volume":"49","author":"Buck","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026081312401031000_jnumed.126.272587v1.2","doi-asserted-by":"crossref","first-page":"597878","DOI":"10.3389\/fendo.2020.597878","article-title":"Impact of the chemokine receptors CXCR4 and CXCR7 on clinical outcome in adrenocortical carcinoma","volume":"11","author":"Chifu","year":"2020","journal-title":"Front Endocrinol (Lausanne)."},{"key":"2026081312401031000_jnumed.126.272587v1.3","doi-asserted-by":"crossref","first-page":"100253","DOI":"10.1016\/j.jbo.2019.100253","article-title":"The role of CXCR4 in multiple myeloma: cells\u2019 journey from bone marrow to beyond","volume":"17","author":"Ullah","year":"2019","journal-title":"J Bone Oncol."},{"key":"2026081312401031000_jnumed.126.272587v1.4","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1007\/s00432-016-2220-6","article-title":"Differential somatostatin and CXCR4 chemokine receptor expression in MALT-type lymphoma of gastric and extragastric origin","volume":"142","author":"Stollberg","year":"2016","journal-title":"J Cancer Res Clin Oncol."},{"key":"2026081312401031000_jnumed.126.272587v1.5","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-411638-2.00002-1"},{"key":"2026081312401031000_jnumed.126.272587v1.6","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.03164.x"},{"key":"2026081312401031000_jnumed.126.272587v1.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2013.10.016"},{"key":"2026081312401031000_jnumed.126.272587v1.8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-10-383406"},{"key":"2026081312401031000_jnumed.126.272587v1.9","doi-asserted-by":"publisher","DOI":"10.7150\/thno.4835"},{"key":"2026081312401031000_jnumed.126.272587v1.10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2174\/1568026619666190201094952","article-title":"Radionuclide-labeled peptides for imaging and treatment of CXCR4- overexpressing malignant tumors","volume":"19","author":"Liu","year":"2019","journal-title":"Curr Top Med Chem."},{"key":"2026081312401031000_jnumed.126.272587v1.11","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.3390\/cancers13235920","article-title":"In vivo targeting of CXCR4\u2014new horizons","volume":"13","author":"Schottelius","year":"2021","journal-title":"Cancers (Basel)."},{"key":"2026081312401031000_jnumed.126.272587v1.12","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.111.098798"},{"key":"2026081312401031000_jnumed.126.272587v1.13","doi-asserted-by":"publisher","DOI":"10.7150\/thno.11251"},{"key":"2026081312401031000_jnumed.126.272587v1.14","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-007-0387-4"},{"key":"2026081312401031000_jnumed.126.272587v1.15","doi-asserted-by":"crossref","first-page":"110447","DOI":"10.1016\/j.apradiso.2022.110447","article-title":"Improved production of 68Ga-pentixafor using cartridge mediated cation exchange purification","volume":"189","author":"Nader","year":"2022","journal-title":"Appl Radiat Isot."},{"key":"2026081312401031000_jnumed.126.272587v1.16","first-page":"e2020097","article-title":"Synthesis, validation and quality controls of [68Ga]-DOTA-pentixafor for PET imaging of chemokine receptor CXCR4 expression","volume":"91","author":"Sammartano","year":"2020","journal-title":"Acta Biomed."},{"key":"2026081312401031000_jnumed.126.272587v1.17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s41181-020-0091-2","article-title":"Fully-automated production of [68Ga]Ga-pentixafor on the module Modular Lab-PharmTracer","volume":"5","author":"Spreckelmeyer","year":"2020","journal-title":"EJNMMI Radiopharm Chem."},{"key":"2026081312401031000_jnumed.126.272587v1.18","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s41181-023-00187-2","article-title":"Automated synthesis and quality control of [68Ga]Ga-pentixafor using the Gaia\/Luna Elysia-Raytest module for CXCR4 PET imaging","volume":"8","author":"Daniel","year":"2023","journal-title":"EJNMMI Radiopharm Chem."},{"key":"2026081312401031000_jnumed.126.272587v1.19","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/RLU.0000000000004629","article-title":"Interobserver agreement rates on C-X-C motif chemokine receptor 4-directed molecular imaging and therapy","volume":"48","author":"Hartrampf","year":"2023","journal-title":"Clin Nucl Med."},{"key":"2026081312401031000_jnumed.126.272587v1.20","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/s11307-024-01940-y","article-title":"Interobserver agreement rates on CXCR4-directed PET\/CT in patients with marginal zone lymphoma","volume":"26","author":"Werner","year":"2024","journal-title":"Mol Imaging Biol."},{"key":"2026081312401031000_jnumed.126.272587v1.21","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.257279"},{"key":"2026081312401031000_jnumed.126.272587v1.22","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.266074"},{"key":"2026081312401031000_jnumed.126.272587v1.23","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.263693"},{"key":"2026081312401031000_jnumed.126.272587v1.24","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00259-023-06489-6","article-title":"Chemokine receptor-targeted PET\/CT provides superior diagnostic performance in newly diagnosed marginal zone lymphoma patients: a head-to-head comparison with [18F]FDG","volume":"51","author":"Kosmala","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026081312401031000_jnumed.126.272587v1.25","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1182\/blood.2021013239","article-title":"CXCR4 PET\/MRI for follow-up of gastric mucosa-associated lymphoid tissue lymphoma after first-line Helicobacter pylori eradication","volume":"139","author":"Mayerhoefer","year":"2022","journal-title":"Blood."},{"key":"2026081312401031000_jnumed.126.272587v1.26","doi-asserted-by":"crossref","first-page":"vi144","DOI":"10.1093\/annonc\/mdt343","article-title":"Gastric marginal zone lymphoma of MALT type: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"24(suppl 6)","author":"Zucca","year":"2013","journal-title":"Ann Oncol."},{"key":"2026081312401031000_jnumed.126.272587v1.27","doi-asserted-by":"crossref","first-page":"20211272","DOI":"10.1259\/bjr.20211272","article-title":"Imaging CXCR4 receptors expression for staging multiple myeloma by using 68Ga-pentixafor PET\/CT: comparison with 18F-FDG PET\/CT","volume":"95","author":"Shekhawat","year":"2022","journal-title":"Br J Radiol."},{"key":"2026081312401031000_jnumed.126.272587v1.28","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00259-019-04605-z","article-title":"Chemokine receptor-4 targeted PET\/CT with 68Ga-pentixafor in assessment of newly diagnosed multiple myeloma: comparison to 18F-FDG PET\/CT","volume":"47","author":"Pan","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026081312401031000_jnumed.126.272587v1.29","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-09-568899"},{"key":"2026081312401031000_jnumed.126.272587v1.30","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.3390\/cancers12082333","article-title":"18F-FDG, 11C-methionine, and 68Ga-pentixafor PET\/CT in patients with smoldering multiple myeloma: imaging pattern and clinical features","volume":"12","author":"Zhou","year":"2020","journal-title":"Cancers (Basel)."},{"key":"2026081312401031000_jnumed.126.272587v1.31","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7150\/thno.16576","article-title":"[68Ga]pentixafor-PET\/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma\u2014comparison to [18F]FDG and laboratory values","volume":"7","author":"Lapa","year":"2017","journal-title":"Theranostics."},{"key":"2026081312401031000_jnumed.126.272587v1.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2008.03.008"},{"key":"2026081312401031000_jnumed.126.272587v1.33","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-12-129395"},{"key":"2026081312401031000_jnumed.126.272587v1.34","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-01102-3"},{"key":"2026081312401031000_jnumed.126.272587v1.35","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.226134"},{"key":"2026081312401031000_jnumed.126.272587v1.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.rcl.2006.10.006"},{"key":"2026081312401031000_jnumed.126.272587v1.37","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-10-185827"},{"key":"2026081312401031000_jnumed.126.272587v1.38","doi-asserted-by":"crossref","first-page":"567","DOI":"10.7150\/thno.48620","article-title":"CXCR4 PET imaging of mantle cell lymphoma using [68Ga]pentixafor: comparison with [18F]FDG-PET","volume":"11","author":"Mayerhoefer","year":"2021","journal-title":"Theranostics."},{"key":"2026081312401031000_jnumed.126.272587v1.39","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8800"},{"key":"2026081312401031000_jnumed.126.272587v1.40","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.142976"},{"key":"2026081312401031000_jnumed.126.272587v1.41","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/RLI.0000000000000469","article-title":"[68Ga]Ga-pentixafor PET\/MRI for CXCR4 imaging of chronic lymphocytic leukemia: preliminary results","volume":"53","author":"Mayerhoefer","year":"2018","journal-title":"Invest Radiol."},{"key":"2026081312401031000_jnumed.126.272587v1.42","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s11307-021-01664-3","article-title":"CXCR4-directed PET\/CT with [68Ga]pentixafor in central nervous system lymphoma: a comparison with [18F]FDG PET\/CT","volume":"24","author":"Chen","year":"2022","journal-title":"Mol Imaging Biol."},{"key":"2026081312401031000_jnumed.126.272587v1.43","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/RLU.0000000000003404","article-title":"Assessment of central nervous system lymphoma based on CXCR4 expression in\u00a0vivo using 68Ga-pentixafor PET\/MRI","volume":"46","author":"Starzer","year":"2021","journal-title":"Clin Nucl Med."},{"key":"2026081312401031000_jnumed.126.272587v1.44","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.193037"},{"key":"2026081312401031000_jnumed.126.272587v1.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.08.2043"},{"key":"2026081312401031000_jnumed.126.272587v1.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2021.08.013"},{"key":"2026081312401031000_jnumed.126.272587v1.47","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1007\/s00259-023-06237-w","article-title":"Sarcoidosis mimicking nodal manifestations of marginal zone lymphoma","volume":"50","author":"Enke","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026081312401031000_jnumed.126.272587v1.48","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1093\/eurheartj\/ehaa598","article-title":"Molecular imaging-guided repair after acute myocardial infarction by targeting the chemokine receptor CXCR4","volume":"41","author":"Hess","year":"2020","journal-title":"Eur Heart J."},{"key":"2026081312401031000_jnumed.126.272587v1.49","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.125.270807"},{"key":"2026081312401031000_jnumed.126.272587v1.50","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13075-026-03747-4","article-title":"Establishing C-X-C motif chemokine receptor 4 as a novel imaging target in giant cell arteritis","volume":"28","author":"Frohlich","year":"2026","journal-title":"Arthritis Res Ther."},{"key":"2026081312401031000_jnumed.126.272587v1.51","doi-asserted-by":"crossref","first-page":"4700","DOI":"10.1007\/s00259-026-07809-2","article-title":"Molecular imaging of lymphatic organs provides prognostic value after acute myocardial infarction","volume":"53","author":"Reiter","year":"2026","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026081312401031000_jnumed.126.272587v1.52","doi-asserted-by":"crossref","first-page":"804","DOI":"10.7150\/thno.102910","article-title":"C-X-C motif chemokine receptor 4-directed PET signal in the arterial tree is not consistently linked to calcified plaque burden and cardiovascular risk","volume":"15","author":"Kosmala","year":"2025","journal-title":"Theranostics."},{"key":"2026081312401031000_jnumed.126.272587v1.53","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/bjh.15096","article-title":"Potential influence of concomitant chemotherapy on CXCR4 expression in receptor directed endoradiotherapy","volume":"184","author":"Lapa","year":"2019","journal-title":"Br J Haematol."},{"key":"2026081312401031000_jnumed.126.272587v1.54","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13550-023-00993-4","article-title":"Influence of corticosteroid treatment on CXCR4 expression in DLBCL","volume":"13","author":"Martin","year":"2023","journal-title":"EJNMMI Res."},{"key":"2026081312401031000_jnumed.126.272587v1.55","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s11307-022-01717-1","article-title":"Impact of Tumor Burden on Normal Organ Distribution in Patients Imaged with CXCR4-Targeted [68Ga]Ga-pentixaFor PET\/CT","volume":"24","author":"Serfling","year":"2022","journal-title":"Mol Imaging Biol."},{"key":"2026081312401031000_jnumed.126.272587v1.56","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s11307-023-01830-9","article-title":"Lymphoma-sink effect in marginal zone lymphoma based on CXCR4-targeted molecular imaging","volume":"25","author":"Kosmala","year":"2023","journal-title":"Mol Imaging Biol."},{"key":"2026081312401031000_jnumed.126.272587v1.57","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00259-023-06547-z","article-title":"CXCR4-directed PET\/CT with [68Ga]Ga-pentixafor in solid tumors\u2014a comprehensive analysis of imaging findings and comparison with histopathology","volume":"51","author":"Dreher","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026081312401031000_jnumed.126.272587v1.58","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.eururo.2023.06.008","article-title":"Prostate-specific membrane antigen reporting and data system version 2.0","volume":"84","author":"Werner","year":"2023","journal-title":"Eur Urol."},{"key":"2026081312401031000_jnumed.126.272587v1.59","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.eururo.2023.02.002","article-title":"Second version of the prostate cancer molecular imaging standardized evaluation framework including response evaluation for clinical trials (PROMISE V2)","volume":"83","author":"Seifert","year":"2023","journal-title":"Eur Urol."},{"key":"2026081312401031000_jnumed.126.272587v1.60","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2967\/jnumed.117.206631","article-title":"SSTR-RADS version 1.0 as a reporting system for SSTR PET imaging and selection of potential PRRT candidates: a proposed standardization framework","volume":"59","author":"Werner","year":"2018","journal-title":"J Nucl Med."},{"key":"2026081312401031000_jnumed.126.272587v1.61","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.125.269914"},{"key":"2026081312401031000_jnumed.126.272587v1.62","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s40658-023-00588-x","article-title":"Harmonization of brain PET images in multi-center PET studies using Hoffman phantom scan","volume":"10","author":"Shekari","year":"2023","journal-title":"EJNMMI Phys."},{"key":"2026081312401031000_jnumed.126.272587v1.63","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.265199"},{"key":"2026081312401031000_jnumed.126.272587v1.64","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1007\/s00259-026-07814-5","article-title":"Lesion-level dual-tracer PET biomarkers predict prognosis in multiple myeloma treated with CXCR4-directed radiopharmaceutical therapy","volume":"53","author":"Xue","year":"2026","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026081312401031000_jnumed.126.272587v1.65","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.264207"},{"key":"2026081312401031000_jnumed.126.272587v1.66","doi-asserted-by":"publisher","DOI":"10.7150\/thno.19050"},{"key":"2026081312401031000_jnumed.126.272587v1.67","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.167361"},{"key":"2026081312401031000_jnumed.126.272587v1.68","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.210997"},{"key":"2026081312401031000_jnumed.126.272587v1.69","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.223420"},{"key":"2026081312401031000_jnumed.126.272587v1.70","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/RLU.0000000000005813","article-title":"Myeloablative radioligand therapy targeting C-X-C Motif chemokine receptor 4 in advanced multiple myeloma","volume":"50","author":"Dreher","year":"2025","journal-title":"Clin Nucl Med."},{"key":"2026081312401031000_jnumed.126.272587v1.71","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1097\/RLU.0000000000001435","article-title":"Investigating the chemokine receptor 4 as potential theranostic target in adrenocortical cancer patients","volume":"42","author":"Bluemel","year":"2017","journal-title":"Clin Nucl Med."},{"key":"2026081312401031000_jnumed.126.272587v1.72","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1007\/s00259-024-06800-z","article-title":"Predictive value of C-X-C motif chemokine receptor 4-directed molecular imaging in patients with advanced adrenocortical carcinoma","volume":"51","author":"Schloetelburg","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026081312401031000_jnumed.126.272587v1.73","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/j.acra.2024.11.064","article-title":"A prospective evaluation of chemokine receptor-4 (CXCR4) overexpression in high-grade glioma using 68Ga-pentixafor (Pars-Cixafor) PET\/CT imaging","volume":"32","author":"Dadgar","year":"2025","journal-title":"Acad Radiol."},{"key":"2026081312401031000_jnumed.126.272587v1.74","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03152-x"},{"key":"2026081312401031000_jnumed.126.272587v1.75","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3390\/cancers17050763","article-title":"Comparing 68Ga-pentixafor, 18F-FDG PET\/CT and chemokine receptor 4 immunohistochemistry staining in breast cancer: a prospective cross sectional study","volume":"17","author":"Hadebe","year":"2025","journal-title":"Cancers (Basel)."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.126.272587","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:40:47Z","timestamp":1786650047000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.126.272587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":75,"alternative-id":["10.2967\/jnumed.126.272587"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.126.272587","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]}}}